Parathyroid Adenoma: Clinical Trials

3 trials for Parathyroid Adenoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Recruiting 1
Phase 21Recruiting 1

Follow Parathyroid Adenoma: new trials by email Literature Review of Parathyroid Adenoma trials Research Report on Parathyroid Adenoma

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT
18Fluorocholine - Parathyroid Adenoma
Phase 2 / Phase 3RecruitingAndrei Iagaru1002023-09-272026-06-24
Trial Comparing 2 Diagnostic Strategies for Preoperative Localization of Parathyroid Adenoma in Primary Hyperparathyroidism:TEMP / CT With Tc99m-sestaMIBI or PET / CT With F18-choline in First Intention
MIBI scintigraphy, F18-choline PET - Parathyroid Adenoma, Hyperparathyroidism
Phase 3CompletedCentre Francois Baclesse592019-09-192023-08-01
Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.
Cinacalcet 30 mg Tablet, Denosumab Inj 60 mg/ml, Placebo tablets - Primary Hyperparathyroidism, Parathyroid Adenoma
Phase 3CompletedPeter Vestergaard462017-03-012021-05-25

Narrower conditions

Parathyroid Neoplasms (3)  ·  Hyperparathyroidism (1)  ·  Hyperparathyroidism, Primary (1)

Broader conditions

Endocrine Gland Neoplasms (3)  ·  Endocrine System Diseases (3)  ·  Head and Neck Neoplasms (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Parathyroid Diseases (3)  ·  Hyperparathyroidism (1)

Interventions

Cinacalcet (1)  ·  Denosumab (1)  ·  Sodium Chloride (1)  ·  Tablets (1)

Sponsors

Andrei Iagaru (1)  ·  Centre Francois Baclesse (1)  ·  Peter Vestergaard (1)

Countries

Denmark (1)  ·  France (1)  ·  United States (1)

Top investigators

Andrei Iagaru, MD (1)  ·  Julius Simoni Leere, MD (1)  ·  Peter Vestergaard, DMSc (1)

Results publications

PMID 32333877, PMID 33413316, PMID 38900416

NIH funding

2016 (1)